Anti-apoptotic signals of granulocyte-macrophage colony-stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils

被引:107
作者
Simon, HU
Yousefi, S
Dibbert, B
Levi-Schaffer, F
Blaser, K
机构
[1] Univ Zurich, Swiss Inst Allergy & Asthma Res, CH-7270 Davos, Switzerland
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pharmacol, IL-91010 Jerusalem, Israel
关键词
apoptosis; cytokine; eosinophil; Jak2; signaling;
D O I
10.1002/eji.1830271256
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytokine-mediated inhibition of eosinophil apoptosis is a mechanism causing tissue eosinophilia. Previously published work suggested that activation of the Lyn-Ras-Raf-1-MAP kinase pathway is obligatory for prevention of eosinophil apoptosis by eosinophil hematopoietins. We demonstrate herein that activation of freshly isolated human blood eosinophils by granulocyte-macrophage colony-stimulating factor (GM-CSF) is associated with increased tyrosine phosphorylation of Jak2. The tyrosine kinase blocker, tyrphostin B42, prevented activation of Jak2 but not Lyn, suggesting that Jak2 is the specific target for tyrphostin B42 in eosinophils. In addition, since Lyn remained unaffected by tyrphostin B42, it is unlikely that Jak2 is required for Lyn activation in this model. To test whether tyrosine phosphorylation of Jak2 is linked to GM-CSF-mediated prolonged eosinophil survival, we determined the effect of tyrphostin B42 on eosinophil viability and apoptosis. Prevention of Jak2 activation by tyrphostin B42 was associated with the inability of GM-CSF to prevent eosinophil apoptosis. These data suggest that disruption of not only the Lyn-Ras-Raf-1-MAP kinase but also the Jak-STAT pathway blocks the ability of eosinophil survival factors to prevent apoptosis in eosinophils.
引用
收藏
页码:3536 / 3539
页数:4
相关论文
共 11 条
[1]  
Bates ME, 1996, J IMMUNOL, V156, P711
[2]   Sorting out the cytokines of asthma [J].
Drazen, JM ;
Arm, JP ;
Austen, KF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :1-5
[3]   Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor [J].
Meydan, N ;
Grunberger, T ;
Dadi, H ;
Shahar, M ;
Arpaia, E ;
Lapidot, Z ;
Leeder, JS ;
Freedman, M ;
Cohen, A ;
Gazit, A ;
Levitzki, A ;
Roifman, CM .
NATURE, 1996, 379 (6566) :645-648
[4]   Jaks, STATs, cytokine signal transduction, and immunoregulation: Are we there yet? [J].
OShea, JJ .
IMMUNITY, 1997, 7 (01) :1-11
[5]  
PAZDRAK K, 1995, J IMMUNOL, V155, P397
[6]   THE INTRACELLULAR SIGNAL-TRANSDUCTION MECHANISM OF INTERLEUKIN-5 IN EOSINOPHILS - THE INVOLVEMENT OF LYN TYROSINE KINASE AND THE RAS-RAF-1-MEK-MICROTUBULE-ASSOCIATED PROTEIN-KINASE PATHWAY [J].
PAZDRAK, K ;
SCHREIBER, D ;
FORSYTHE, P ;
JUSTEMENT, L ;
ALAM, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1827-1834
[7]  
PAZDRAK K, 1995, J IMMUNOL, V155, P4454
[8]  
Simon HU, 1997, J IMMUNOL, V158, P3902
[9]   INTERLEUKIN-5 SIGNALING IN HUMAN EOSINOPHILS INVOLVES JAK2 TYROSINE KINASE AND STAT1-ALPHA [J].
VANDERBRUGGEN, T ;
CALDENHOVEN, E ;
KANTERS, D ;
COFFER, P ;
RAAIJMAKERS, JAM ;
LAMMERS, JWJ ;
KOENDERMAN, L .
BLOOD, 1995, 85 (06) :1442-1448
[10]  
Wei S, 1996, J IMMUNOL, V157, P5155